LabCentral Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
111
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$250K
- Investors
-
7
LabCentral General Information
Description
Provider of business incubation and acceleration services intended to help startup entrepreneurs grow their businesses. The company's services include mentorship, coaching, workspaces, organizing promotional events, fully permitted facilities, access to shared equipment, and a collaborative community, enabling entrepreneurs and scientists to advance their research and bring creativity to market efficiently.
Contact Information
Website
www.labcentral.orgCorporate Office
- 700 Main Street
- Cambridge, MA 02139
- United States
Corporate Office
- 700 Main Street
- Cambridge, MA 02139
- United States
LabCentral Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Grant | 27-Jan-2022 | $250K | Completed | Generating Revenue | ||
| 4. Later Stage VC | 17-Feb-2021 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 04-Oct-2019 | Completed | Generating Revenue | |||
| 2. Grant | 22-Dec-2014 | $5M | Completed | Generating Revenue | ||
| 1. Early Stage VC | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
LabCentral Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
LabCentral Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| U.S. Department of Commerce | Government | |||
| Thermo Fisher Scientific | Corporation | Minority | ||
| Waters | Corporation | Minority | ||
| Astellas Pharma | Corporation | Minority | ||
| MRL Ventures Fund | Corporate Venture Capital | Minority |
LabCentral Investments (255)
LabCentral’s most recent deal was a Accelerator/Incubator with PhagePro. The deal was made on 24-Sep-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| PhagePro | 24-Sep-2026 | Accelerator/Incubator | Drug Discovery | ||
| Transfyr | 26-Aug-2026 | Seed Round | Discovery Tools (Healthcare) | ||
| Meteor Biosciences | 16-Jun-2026 | Accelerator/Incubator | Other Pharmaceuticals and Biotechnology | ||
| Adelle Diagnostics | 27-Mar-2026 | Accelerator/Incubator | Decision/Risk Analysis | ||
| Alces Bioworks | 27-Mar-2026 | Accelerator/Incubator | Discovery Tools (Healthcare) |
LabCentral FAQs
-
When was LabCentral founded?
LabCentral was founded in 2013.
-
Where is LabCentral headquartered?
LabCentral is headquartered in Cambridge, MA.
-
What is the size of LabCentral?
LabCentral has 111 total employees.
-
What industry is LabCentral in?
LabCentral’s primary industry is Other Commercial Services.
-
Is LabCentral a private or public company?
LabCentral is a Private company.
-
What is LabCentral’s current revenue?
The current revenue for LabCentral is .
-
How much funding has LabCentral raised over time?
LabCentral has raised $35.4M.
-
Who are LabCentral’s investors?
U.S. Department of Commerce, Thermo Fisher Scientific, Waters, Astellas Pharma, and MRL Ventures Fund are 5 of 7 investors who have invested in LabCentral.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
